The Effects of Chemotherapy or Radiotherapy on Reproductive and Sexual Health of Early Onset Colorectal Cancer Patients

Status: Recruiting
Location: See all (8) locations...
Intervention Type: Diagnostic test, Behavioral
Study Type: Observational
SUMMARY

The purpose of this study is to find out how cancer treatments (chemotherapy and/or radiation therapy) affect reproductive and sexual health in people with early onset colorectal cancer. The study researchers will observe and track changes in hormone levels and in sexual and reproductive health in people with early onset colorectal cancer. This information will help researchers know more about how cancer treatments affect reproductive and sexual health, including the ability to have children (fertility).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: f
View:

• 18-40 years of age and premenopausal (female) or 18-50 years of age (male) at time of diagnosis

• Histologic diagnosis of colorectal adenocarcinoma

• Able and willing to participate in the informed consent process

• Eligible for curative adjuvant or neoadjuvant therapy for colon or rectal cancer

• Willing and able to complete protocol questionnaires

• Rectal patients only: Individuals who will be receiving chemotherapy, followed by chemoradiotherapy (ChemoRT)

Locations
United States
Connecticut
Hartford Healthcare Cancer Alliance (Data collection only)
RECRUITING
Hartford
New Jersey
Memorial Sloan Kettering Basking Ridge
RECRUITING
Basking Ridge
Memorial Sloan Kettering Monmouth
RECRUITING
Middletown
Memorial Sloan Kettering Bergen
RECRUITING
Montvale
New York
Memorial Sloan Kettering Cancer Center at Suffolk - Commack
RECRUITING
Commack
Memorial Sloan Kettering Westchester
RECRUITING
Harrison
Memorial Sloan Kettering Cancer Center
RECRUITING
New York
Memorial Sloan Kettering Nassau
RECRUITING
Rockville Centre
Contact Information
Primary
Andrea Cercek, MD
cerceka@mskcc.org
646-888-4189
Backup
Paul Romesser, MD
romessep@mskcc.org
646-888-2118
Time Frame
Start Date: 2021-03-18
Estimated Completion Date: 2026-03-18
Participants
Target number of participants: 120
Treatments
Participants with Colon Cancer
This patient population will have hormone biomarker analysis, questionnaire (QOL) administration, and, if the patient is male, semen analysis
Participants with Rectal Cancer
This patient population will have hormone biomarker analysis, QOL administration, and, if the patient is male, semen analysis
Related Therapeutic Areas
Sponsors
Leads: Memorial Sloan Kettering Cancer Center

This content was sourced from clinicaltrials.gov